Identification of Epstein-Barr Virus Lytic and Latent RNA Transcripts in Post-transplant Lymphoproliferative Disorder

International Journal of Surgical Pathology

Volumn 3, Issue 2, 1995, Pages 119-130

  Montone, Kathleen T ^a   Hodinka, Richard L ^b   Tomaszewski, John E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Epstein Barr virus; in sittr hybridization; post transplant lymphoproliferative disorders

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RNA TRANSCRIPTION; TRANSPLANTATION; VIRUS INFECTION;

EID: 0029584154     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/106689699510030206     Document Type: Article

References (36)

1. Frizerra G Hanto DW Gajl-Peczalalska K Rosai J McKenna RW Sibley RK Holahan KD Lindquist LL. Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41: 4262–4279, 1981.
2. Hanto DW Gajl-Peczalalska K Frizzera G Arthur DC Balfour HH Jr McClain K Simmon RL Najararian JS. Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation: Clinical, pathological, and virological findings and implication for therapy. Ann Surg 198: 356–369, 1983.
3. Ho M Miller G Atchison RW Breinig MK Dummer S Andimen W Starzl T Eastman R Griffith BP Hardesty RL Bahnson HT Hakal TR Rosenthal JT, Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 152: 876–885, 1985.
4. Nalesnik M Jaffe R Starzl TE Demetris AJ Porter K Burnham JA Makowa L Ho M Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133: 173–192, 1988.
5. Starzl TE Porter KA Iwatsuki S Griffith BP Rosenthal JT Hakala TR Shaw BW Hardesty RL. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1: 583–587, 1984.
6. Clearly ML Nalesnik MA Shearer WT Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72: 349–352, 1988.
7. Locker J Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135: 977–987, 1989.
8. Montone KT Friedman H Hodinka RL Hicks DG Kant JA Tomaszewski JE. In situ hybridization for Epstein-Barr virus Notl repeats in posttransplant lymphoproliferative disorder. Mod Pathol 5: 292–302, 1992.
9. Randhawa PS Jaffe R Demetris AJ Nalesnik M Starzl TE Chen YY Weiss LM. Expression of Epstein-Barr virus small RNA (by EBER-1 gene) in liver specimens from transplant recipients with post-transplantation disease. N Engl J Med 137: 1710–1714, 1992.
10. Purtilo DT. Opportunistic cancers in patients with immunodeficiency syndromes. Arch Pathol Lab Med 111: 1123–1129, 1987.
11. Purtilo DT Strobach RS Okanao M Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 67: 5–23, 1992.
12. Wang F Gregory CD Rowe M. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci 84: 3452–3456, 1987.
13. Fischer A Blanche S Le Bidois J Bordigoni P Garnier GL Niadet P Morinet F Le Deist F Fischer AM Griscelli C. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324: 1451–1456, 1991.
14. Katz BZ Raab-Traub N Miller G. Latent and replicating forms of Epstein-Barr virus in lymphomas and lymphoproliferative diseases. J Infect Dis 1989; 160: 589–598, 1989.
15. Pallesen G Hamilton D Rowe M Lisse I Ralfkiaer E Sandvej K Young LS. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 165: 289–299, 1991.
16. Rowe M Young LS Crocker J Stokes H Henderson S Rickinson AB. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173: 147–158, 1991.
17. Montone KT Tomaszewski JE. In situ hybridization protocol for detection of overall preservation of mRNA in fixed tissues with a poly d(T) oligonucleotide probe. J Histotechnol 16: 315–322, 1993.
18. Rooney CM Rowe DT Ragot T Farrell PJ. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an EBV promoter and induces the virus productive cycle. J Virol 63: 3109–3116, 1989.
19. Beisel C Tanner J Matsuo T Thorley-Lawson D Kezdy F Kieff E. Two major outer envelope glycoprotein of Epstein-Barr virus are encoded by the same gene. J Virol 54: 665–674, 1985.
20. Howe JG Mei-Di Shu Isolation and characterization of the genes for two small RNAs of herpes virus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. J Virol 62: 2790–2798, 1988.
21. Hatfull G Bankiet AT Barrell BG Farrell PJ. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164: 334–340, 1988.
22. Speck SH Strominger JL. Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: A potentially polycistronic message generated by long-range splicing of several exons. Proc Natl Acad Sci 82: 8305–8309, 1985.
23. Dambaugh T Hennessey K Chamnankit L Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci 81: 7632–7636, 1984.
24. Altschul SF Gish W Miller W Myers EW Lipman DJ. Basic local alignment search tool. J Mol Biol 215: 403–410, 1990.
25. Montone KT Tomaszewski JE. In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma. J Clin Lab Anal 7: 188–195, 1993.
26. Wang JY Montone KT. A rapid simple in situ hybridization method for herpes simplex virus employing a synthetic biotin labeled oligonucleotide probe: A comparison with immunohistochemical methods for HSV detection. J Clin Lab Analysis 8: 105–115, 1994.
27. Wang D Liebowitz D Wang F Gregory C Rickinson A Larson R Springer T Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol 55: 4173–4184, 1988.
28. Young L Alfieri C Hennessy K Evans H O'Hara C Anderson KC Ritz KC Shapiro RS Rickinson A Kieff E Cohen JI. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321: 1080–1085, 1989.
29. Thomas JA Hotchin NA Allday MJ Amlot P Rose M Yacoub M Crawford DH. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49: 944–953, 1990.
30. Strauch B Siegel N Andrews L-L Miller G. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1: 234–237, 1974.
31. Marker SC Ascher NL Kalis JM Simmons RL Najarian JS Balfour HH. Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery 85: 433–440, 1979.
32. Dyson PJ Farrell PJ. Chromatin structure of Epstein-Barr virus. J Gen Virol 66: 1931–1940, 1985.
33. Young LS Finerty S Brooks L Scullion F Rickinson AB Morgan AJ. Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins. J Virol 63: 1967–1974, 1989.
34. Rea D Delecluse H-J Hamilton-Dutoit SJ Marelle L Joab I Edelman L Finet JF Raphael M. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphoma. Ann Oncol 5(suppl)1: 113–116, 1994.
35. Bashir R Luka J Cheloha K Chamberlain M Hochberg F. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 43: 2358–2362, 1993.
36. Mosier DE Pichio GR Kirven MB Garnier JL Torbett BE Baird SM Kobayashi R Kipps TJ. EBV induced human B cell lyphomas in hu-PBL SCID mice. AIDS Res Hum Retroviruses 8: 735–739, 1992.